Who invested in Concerto Biosciences?
Concerto Biosciences's investors include Safar Partners, Horizons Ventures, Alumni Ventures, 8VC and Golden Seeds, and 3 more on record.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$23Mraised across 2 rounds since 2022, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Reported by Firms' own news pages
From the SEC filings it signed: 3 on the team.
On the board, as filediSarah LuppinoVera Schroeder
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Concerto Biosciences's investors include Safar Partners, Horizons Ventures, Alumni Ventures, 8VC and Golden Seeds, and 3 more on record.
Concerto Biosciences has raised $23M across 2 rounds since 2022. One round did not disclose an amount, so the total is a floor.
Concerto Biosciences's most recent round was a Venture in Sept 2024.
Concerto Biosciences's largest round on record is $23M (Series A), in Nov 2022, led by Safar Partners.
Concerto Biosciences's first round on record, in Nov 2022, was backed by Safar Partners, Horizons Ventures and M/VENTURES and 1 others.
Concerto Biosciences's latest named round is a Venture, in Sept 2024.
Concerto Biosciences is based in the United States.
Safar Partners led the Series A in 2022.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.